Evidence map›Paper›PMID 27716192›Full record

ArticleBMC ophthalmology2016

Sequence analysis of four vitamin D family genes (VDR, CYP24A1, CYP27B1 and CYP2R1) in Vogt-Koyanagi-Harada (VKH) patients: identification of a potentially pathogenic variant in CYP2R1.

Ma'an Abdullah Al-Barry, Alia M Albalawi, Mohammed Abu Sayf, Abdulrahman Badawi, Sibtain Afzal, Muhammad Latif, Mohammed I Samman, Sulman Basit

Open access · goldAbstract read
In one paragraph

Article in BMC ophthalmology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Vitamin D and Ocular Diseases: A Systematic Review.International journal of molecular sciences · 2022
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Ma'an Abdullah Al-BarryCollege of Medicine, Taibah University Almadinah Almunawarah, Medina, Kingdom of Saudi Arabia.
Alia M AlbalawiCenter for Genetics and Inherited Diseases, Taibah University Almadinah Almunawarah, Medina, 30001, Kingdom of Saudi Arabia.
Mohammed Abu SayfCollege of Medicine, Taibah University Almadinah Almunawarah, Medina, Kingdom of Saudi Arabia.
Abdulrahman BadawiCollege of Medicine, Taibah University Almadinah Almunawarah, Medina, Kingdom of Saudi Arabia.
Sibtain AfzalPrince Naif Center for Immunology Research, College of Medicine, King Saud University, Riyadh, 11472, Saudi Arabia.
Muhammad LatifCenter for Genetics and Inherited Diseases, Taibah University Almadinah Almunawarah, Medina, 30001, Kingdom of Saudi Arabia.
Mohammed I SammanCenter for Genetics and Inherited Diseases, Taibah University Almadinah Almunawarah, Medina, 30001, Kingdom of Saudi Arabia.
Sulman BasitCenter for Genetics and Inherited Diseases, Taibah University Almadinah Almunawarah, Medina, 30001, Kingdom of Saudi Arabia. sbasit.phd@gmail.com.
Taibah University · SAKing Saud University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundVKH is a rare autoimmune disease. Decreased level of vitamin D has recently been found to be involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease. This study was designed to screen the vitamin D pathway genes for pathogenic mutations, if any, in VKH patients.

methodsGenomic DNA was extracted from blood samples collected from patients with VKH disease and healthy controls. Entire coding region, exon-intron junctions of four genes were sequenced in DNA from 39 Saudi VKH patients and 50 ethnically matched healthy individuals. All patients and controls were unrelated.

resultsVitamin D levels in VKH patients were found either insufficient (21-29 ng/mL) or deficient (<20 ng/mL). Sequencing analysis of the VDR, CYP24A1, CYP27B1 and CYP2R1 detected twelve nucleotide changes in these genes in our cohort of 39 patients; 4 of which were non-coding, 6 were synonymous coding and 2 were non-synonymous coding sequence changes. All synonymous coding variants were benign polymorphisms with no apparent clinical significance. A non-synonymous coding sequence variant (c.2 T > C; p.1Met?) found in VDR is an initiation coding change and was detected in control individuals as well, while another variant (c.852G > A; p.284 M > I) found in CYP2R1 is predicted to be disease causing by mutationtaster software. This potentially pathogenic variant was found in 17 out of 39 VKH patients.

conclusionsScreening of four Vitamin D pathway genes in 39 VKH patients shows that a potentially pathogenic sequence variant in CYP2R1 may cause VKH in a subset of patients. These findings support the previous observation that low vitamin D levels might play a role in VKH pathogenesis and mutations in genes involved in vitamin D anabolism and catabolism might be of importance in VKH pathobiology.

Indexed as

Genetic Predisposition to Disease25-Hydroxyvitamin D3 1-alpha-HydroxylaseAdolescentAdultCase-Control StudiesChildCholestanetriol 26-MonooxygenaseCytochrome P-450 Enzyme SystemCytochrome P450 Family 2FemaleGene FrequencyGenotypeHumansMaleMiddle AgedReceptors, Calcitriol25-Hydroxyvitamin D3 1-alpha-HydroxylaseCholestanetriol 26-MonooxygenaseCYP24A1 protein, humanCYP27B1 protein, humanCYP2R1 protein, humanCytochrome P-450 Enzyme SystemCytochrome P450 Family 2Receptors, CalcitriolVDR protein, humanVitamin DVitamin D3 24-HydroxylaseGenesMutationsVitamin DVogt-Koyanagi-Harada

Identifiers

PMID27716192
PMCPMC5050582
OpenAlexW2527839622

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.